Craig-Hallum analyst Jeff Van Rhee initiated coverage of Cellebrite with a Buy rating and $11 price target.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CLBT:
- Cellebrite to Report Second-Quarter 2023 Financial Results on August 8, 2023
- Cellebrite price target raised to $6.75 from $6.15 at BofA
- UPDATE – Cellebrite Announces Innovative Case-Closing Technology; Raising the Bar for Modern Investigations
- Cellebrite Announces Innovative Case-Closing Technology; Raising the Bar for Modern Investigations
- Cellebrite Bolsters Digital Intelligence Capabilities for Latin American Nation’s Federal Forces and Expands Investigative Power around Crypto Crime